Huntington’s Disease Clinical Trials Corner: March 2024
Journal of Huntington's Disease · 2024-03-29 · 13 (1) · 1-14
DOI: 10.3233/jhd-240017 ↗Abstract
In this edition of the Huntington’s Disease Clinical Trials Update, we expand on the ongoing program from VICO Therapeutics and on the recently terminated VIBRANT-HD clinical trials. We also discuss updates from uniQure’s AMT-130 program and PTC therapeutics’ trial of PTC518 and list all currently registered and ongoing clinical trials in Huntington’s disease.
EUVIMED